Background: COVID-19 poses significant challenges for care of patients with chronic inflammatory skin diseases including psoriasis.
Objectives: To investigate changes in treatment and/or appointments for psoriasis patients in a German university hospital due to the pandemic.
Materials & Methods: A postal survey was conducted between May 15 and June 15, 2020.